2006
DOI: 10.1111/j.1471-4159.2006.03777.x
|View full text |Cite
|
Sign up to set email alerts
|

Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline

Abstract: Parkinson's disease is a neurodegenerative disorder which is in most cases of unknown etiology. Mutations of the Park-2 gene are the most frequent cause of familial parkinsonism and parkin knockout (PK-KO) mice have abnormalities that resemble the clinical syndrome. We investigated the interaction of genetic and environmental factors, treating midbrain neuronal cultures from PK-KO and wild-type (WT) mice with rotenone (ROT). ROT (0.025-0.1 lM) produced a dosedependent selective reduction of tyrosine hydroxylas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

8
93
1
2

Year Published

2007
2007
2013
2013

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 141 publications
(104 citation statements)
references
References 72 publications
8
93
1
2
Order By: Relevance
“…APO, which needs activation by peroxidases, inhibits the association of the NADPH oxidase cytosolic subunits (Stolk et al, 1994). It is the most commonly used NADPH oxidase inhibitor and has been reported to decrease NADPH oxidasemediated ROS in previous studies (Gao et al, 2002;Casarejos et al, 2006;Wang et al, 2006;Abramov et al, 2007). AEBSF, a non-specific serine protease inhibitor, deters NADPH oxidase activation by inhibiting the subunit p47 phox (Megyeri et al, 1995;Diatchuk et al, 1997).…”
Section: Discussionmentioning
confidence: 99%
“…APO, which needs activation by peroxidases, inhibits the association of the NADPH oxidase cytosolic subunits (Stolk et al, 1994). It is the most commonly used NADPH oxidase inhibitor and has been reported to decrease NADPH oxidasemediated ROS in previous studies (Gao et al, 2002;Casarejos et al, 2006;Wang et al, 2006;Abramov et al, 2007). AEBSF, a non-specific serine protease inhibitor, deters NADPH oxidase activation by inhibiting the subunit p47 phox (Megyeri et al, 1995;Diatchuk et al, 1997).…”
Section: Discussionmentioning
confidence: 99%
“…Minocycline, an antibiotic known to inhibit microglial proliferation, attenuated the neurotoxicity due to 6-hydroxydopamine, MPTP and rotenone (Casarejos et al, 2006;Croisier et al, 2005). These studies support the important role of microglia in the initiation and progression of PD.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have provided strong evidence for microglia to produce ROS through activation of NADPH oxidase (Casarejos et al, 2006;Choi et al, 2005) and involvement of this enzyme in a number of neurodegenerative diseases (Sun et al, 2007). This enzyme is comprised of multiple subunits in the cytosol and plasma membrane and assembly of the subunits is initiated by phosphorylation of the cytosolic subunits, e.g., p47phox, p67phox, p40phox, and translocation to the membrane subunits, e.g., gp91phox, p22phox (Choi et al, 2005;Sumimoto et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…But parkin null cells are more susceptible to additional insults such as treatment with rotenone, a mitochondrial toxin [14], calcium channel antagonists, such as cinnarizine [15] or to the effects of aging, when the supportive function of glia is reduced and the increased production of GSH collapses [16].…”
Section: Introductionmentioning
confidence: 99%
“…Parkin enhances the survival of the dopamine neurons [14,[17][18][19][20][21]. Parkin dysfunction impairs astrocytic function and contributes to the pathogenesis of parkin-linked AR-PD [22].…”
Section: Introductionmentioning
confidence: 99%